Interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
Date | Title & Description | Contributors |
---|---|---|
2024-12-06 |
IgAN Explained: Key Differences from Other Kidney Conditions Guest: Mohamed Ibrahim, MB, BCh IgA nephropathy (IgAN) is a rare autoimmune kidney disease in which IgA deposits damage kidney filters, causing symptoms like proteinuria and swelling. While symptoms can overlap with other kidney diseases, IgA... |
|
2024-11-19 | Guest: Jennifer Moore, MS, RDN, CSR, LDN Host: Charles Turck, PharmD, BCPS, BCCCP IgA nephropathy, or IgAN, is a rare kidney disease that requires dietary changes to maintain kidney health and function while supporting other organ systems... | |
2024-11-11 |
Intraoperative Opioid Waste: Critical Impacts and Prevention Strategies Host: Charles Turck, PharmD, BCPS, BCCCP Guest: John Hertig PharmD, MS, CPPS Not only does intraoperative opioid waste have serious environmental, regulatory, and financial costs, but it can also threaten the quality of patient care and s... |
|
2024-11-01 | Host: Gates B. Colbert, MD Guest: Kelly Helm Over 35 million people in the United States suffer from some form of chronic kidney disease, but many of them lack the support and education to navigate their condition and receive the best pos... | |
2024-10-31 |
Improving Adherence to CRC Screening: A Primary Care Physician’s Guide Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sara Enslin, PA Current colorectal cancer (CRC) screening rates are low, putting patients at risk of developing more advanced disease and even increased mortality. Primary care physicians pl... |
|
2024-10-09 |
Poster Pearl: Comparing Endorsed vs. Non-Endorsed CRC Screening Tests Host: Matt Birnholz, MD The United States Preventative Services Task Force endorses multiple screening options for patients at average-risk of colorectal cancer (CRC). These options include colonoscopy, multi-target stool DNA, and the fecal i... |
|
2024-10-09 |
Poster Pearl: Comparing the Efficiency of Stool-Based CRC Screening Tests Host: Matt Birnholz, MD For patients at average risk of colorectal cancer (CRC), the United States Preventative Services Task Force recommends screening with either the multi-target stool DNA test or fecal immunochemical test. But in light of... |
|
2024-09-30 |
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster Host: Jennifer Caudle, DO Guest: A. Mark Fendrick, MD Approximately 40 percent of the eligible U.S. population are not up to date with their colorectal cancer (CRC) screenings, which inspired this study that was presented at Digestive Dis... |
|
2024-05-14 |
COPD and Alpha-1: Addressing Testing Barriers in Primary Care Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Brian Smith, MD, MPH According to the current recommendations, we should be testing all patients with COPD for alpha-1 antitrypsin deficiency (AATD). But unfortunately, there are many barrie... |
|
2024-05-14 |
Managing AATD in COPD: Lessons from a Patient Case and Clinical Practice Host: Charles Turck, PharmD, BCPS, BCCCP Guest: David C. Mares, MD It’s absolutely critical to proactively detect alpha-1 antitrypsin deficiency (AATD) in our patients with COPD, but it’s just as important to know how to manage patients w... |